Annual report
6315.TEDINET S100YERT
Period2025-04-01 → 2026-03-31
Filed2026-06-19
StandardJapan GAAP
ConsolidatedYes
Data checks24 of 24 passed
Key figures · 148
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥54.4bn | 2025-04-01 → 2026-03-31 | Cons. | Net sales |
| Revenue | ¥53.5bn | 2024-04-01 → 2025-03-31 | Cons. | Net sales |
| Revenue | ¥50.5bn | 2023-04-01 → 2024-03-31v | Cons. | Net sales (5-year summary) |
| Revenue | ¥53.8bn | 2022-04-01 → 2023-03-31v | Cons. | Net sales (5-year summary) |
| Revenue | ¥50.7bn | 2021-04-01 → 2022-03-31v | Cons. | Net sales (5-year summary) |
| Operating income | ¥6.9bn | 2025-04-01 → 2026-03-31 | Cons. | Operating income |
| Operating income | ¥8.9bn | 2024-04-01 → 2025-03-31 | Cons. | Operating income |
| Ordinary income | ¥6.9bn | 2025-04-01 → 2026-03-31 | Cons. | Ordinary income |
| Ordinary income | ¥9.4bn | 2024-04-01 → 2025-03-31 | Cons. | Ordinary income |
| Ordinary income | ¥9.1bn | 2023-04-01 → 2024-03-31v | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | ¥10.2bn | 2022-04-01 → 2023-03-31v | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | ¥11.7bn | 2021-04-01 → 2022-03-31v | Cons. | Ordinary income loss (5-year summary) |
| Profit before tax | ¥7.0bn | 2025-04-01 → 2026-03-31 | Cons. | Income before income taxes |
| Profit before tax | ¥11.2bn | 2024-04-01 → 2025-03-31 | Cons. | Income before income taxes |
| Net income (owners) | ¥4.6bn | 2025-04-01 → 2026-03-31 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | ¥8.1bn | 2024-04-01 → 2025-03-31 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | ¥6.4bn | 2023-04-01 → 2024-03-31v | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | ¥7.3bn | 2022-04-01 → 2023-03-31v | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | ¥8.1bn | 2021-04-01 → 2022-03-31v | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income | ¥4.6bn | 2025-04-01 → 2026-03-31 | Cons. | Profit loss |
| Net income | ¥8.1bn | 2024-04-01 → 2025-03-31 | Cons. | Profit loss |
| Total assets | ¥106.3bn | at 2026-03-31 | Cons. | Assets |
| Total assets | ¥83.2bn | at 2025-03-31 | Cons. | Assets |
| Total assets | ¥87.9bn | at 2024-03-31v | Cons. | Total assets (5-year summary) |
| Total assets | ¥73.5bn | at 2023-03-31v | Cons. | Total assets (5-year summary) |
| Total assets | ¥71.3bn | at 2022-03-31v | Cons. | Total assets (5-year summary) |
| Total liabilities | ¥35.7bn | at 2026-03-31 | Cons. | Liabilities |
| Total liabilities | ¥21.8bn | at 2025-03-31 | Cons. | Liabilities |
| Net assets / equity | ¥70.6bn | at 2026-03-31 | Cons. | Net assets |
| Net assets / equity | ¥61.4bn | at 2025-03-31 | Cons. | Net assets |
| Net assets / equity | ¥58.4bn | at 2024-03-31v | Cons. | Net assets |
| Net assets / equity | ¥47.6bn | at 2023-03-31v | Cons. | Net assets (5-year summary) |
| Net assets / equity | ¥41.1bn | at 2022-03-31v | Cons. | Net assets (5-year summary) |
| Cash and deposits | ¥28.4bn | at 2026-03-31 | Cons. | Cash and deposits |
| Cash and deposits | ¥21.3bn | at 2025-03-31 | Cons. | Cash and deposits |
| Cash & equivalents | ¥26.4bn | at 2026-03-31 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥20.4bn | at 2025-03-31 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥20.5bn | at 2024-03-31v | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥16.4bn | at 2023-03-31v | Cons. | Cash and cash equivalents (5-year summary) |
| Cash & equivalents | ¥12.3bn | at 2022-03-31v | Cons. | Cash and cash equivalents (5-year summary) |
| Operating cash flow | ¥4.1bn | 2025-04-01 → 2026-03-31 | Cons. | Net cash provided by used in operating activities |
| Operating cash flow | ¥10.4bn | 2024-04-01 → 2025-03-31 | Cons. | Net cash provided by used in operating activities |
| Operating cash flow | ¥9.7bn | 2023-04-01 → 2024-03-31v | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | ¥2.8bn | 2022-04-01 → 2023-03-31v | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | ¥6.4bn | 2021-04-01 → 2022-03-31v | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Investing cash flow | −¥5.5bn | 2025-04-01 → 2026-03-31 | Cons. | Net cash provided by used in investment activities |
| Investing cash flow | −¥4.8bn | 2024-04-01 → 2025-03-31 | Cons. | Net cash provided by used in investment activities |
| Investing cash flow | −¥2.8bn | 2023-04-01 → 2024-03-31v | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | −¥2.7bn | 2022-04-01 → 2023-03-31v | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | −¥6.6bn | 2021-04-01 → 2022-03-31v | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Financing cash flow | ¥6.4bn | 2025-04-01 → 2026-03-31 | Cons. | Net cash provided by used in financing activities |
| Financing cash flow | −¥5.1bn | 2024-04-01 → 2025-03-31 | Cons. | Net cash provided by used in financing activities |
| Financing cash flow | −¥3.5bn | 2023-04-01 → 2024-03-31v | Cons. | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | ¥4.0bn | 2022-04-01 → 2023-03-31v | Cons. | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | ¥1.9bn | 2021-04-01 → 2022-03-31v | Cons. | Net cash provided by used in financing activities (5-year summary) |
| EPS (basic) | ¥61.22 | 2025-04-01 → 2026-03-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥108.28 | 2024-04-01 → 2025-03-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥85.9 | 2023-04-01 → 2024-03-31v | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥97.9 | 2022-04-01 → 2023-03-31v | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥108.36 | 2021-04-01 → 2022-03-31v | Cons. | Basic earnings loss per share (5-year summary) |
| Net assets per share | ¥941.14 | at 2026-03-31 | Cons. | Net assets per share (5-year summary) |
| Net assets per share | ¥818.41 | at 2025-03-31 | Cons. | Net assets per share (5-year summary) |
| Net assets per share | ¥779.18 | at 2024-03-31v | Cons. | Net assets per share (5-year summary) |
| Net assets per share | ¥629.13 | at 2023-03-31v | Cons. | Net assets per share (5-year summary) |
| Net assets per share | ¥542.86 | at 2022-03-31v | Cons. | Net assets per share (5-year summary) |
| Equity ratio | 66.4% | at 2026-03-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 73.8% | at 2025-03-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 66.5% | at 2024-03-31v | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 64.3% | at 2023-03-31v | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 57.1% | at 2022-03-31v | Cons. | Equity to asset ratio (5-year summary) |
| ROE | 7.0% | 2025-04-01 → 2026-03-31 | Cons. | Rate of return on equity (5-year summary) |
| ROE | 13.6% | 2024-04-01 → 2025-03-31 | Cons. | Rate of return on equity (5-year summary) |
| ROE | 12.2% | 2023-04-01 → 2024-03-31v | Cons. | Rate of return on equity (5-year summary) |
| ROE | 16.7% | 2022-04-01 → 2023-03-31v | Cons. | Rate of return on equity (5-year summary) |
| ROE | 22.6% | 2021-04-01 → 2022-03-31v | Cons. | Rate of return on equity (5-year summary) |
| Employees | 2,211 | at 2026-03-31 | Cons. | Number of employees |
| Employees | 2,099 | at 2025-03-31 | Cons. | Number of employees |
| Employees | 1,985 | at 2024-03-31v | Cons. | Number of employees |
| Employees | 1,876 | at 2023-03-31v | Cons. | Number of employees |
| Employees | 1,817 | at 2022-03-31v | Cons. | Number of employees |
| Revenue | ¥41.5bn | 2025-04-01 → 2026-03-31 | Standalone | Net sales |
| Revenue | ¥41.9bn | 2024-04-01 → 2025-03-31 | Standalone | Net sales |
| Revenue | ¥41.7bn | 2023-04-01 → 2024-03-31v | Standalone | Net sales (5-year summary) |
| Revenue | ¥42.4bn | 2022-04-01 → 2023-03-31v | Standalone | Net sales (5-year summary) |
| Revenue | ¥42.5bn | 2021-04-01 → 2022-03-31v | Standalone | Net sales (5-year summary) |
| Operating income | ¥100m | 2025-04-01 → 2026-03-31 | Standalone | Operating income |
| Operating income | ¥2.9bn | 2024-04-01 → 2025-03-31 | Standalone | Operating income |
| Ordinary income | ¥171m | 2025-04-01 → 2026-03-31 | Standalone | Ordinary income |
| Ordinary income | ¥3.1bn | 2024-04-01 → 2025-03-31 | Standalone | Ordinary income |
| Ordinary income | ¥5.0bn | 2023-04-01 → 2024-03-31v | Standalone | Ordinary income loss (5-year summary) |
| Ordinary income | ¥4.6bn | 2022-04-01 → 2023-03-31v | Standalone | Ordinary income loss (5-year summary) |
| Ordinary income | ¥6.6bn | 2021-04-01 → 2022-03-31v | Standalone | Ordinary income loss (5-year summary) |
| Profit before tax | ¥252m | 2025-04-01 → 2026-03-31 | Standalone | Income before income taxes |
| Profit before tax | ¥4.9bn | 2024-04-01 → 2025-03-31 | Standalone | Income before income taxes |
| Net income | ¥41m | 2025-04-01 → 2026-03-31 | Standalone | Profit loss |
| Net income | ¥3.7bn | 2024-04-01 → 2025-03-31 | Standalone | Profit loss |
| Net income | ¥3.7bn | 2023-04-01 → 2024-03-31v | Standalone | Net income loss (5-year summary) |
| Net income | ¥3.4bn | 2022-04-01 → 2023-03-31v | Standalone | Net income loss (5-year summary) |
| Net income | ¥4.9bn | 2021-04-01 → 2022-03-31v | Standalone | Net income loss (5-year summary) |
| Total assets | ¥64.1bn | at 2026-03-31 | Standalone | Assets |
| Total assets | ¥52.6bn | at 2025-03-31 | Standalone | Assets |
| Total assets | ¥60.0bn | at 2024-03-31v | Standalone | Total assets (5-year summary) |
| Total assets | ¥50.6bn | at 2023-03-31v | Standalone | Total assets (5-year summary) |
| Total assets | ¥51.0bn | at 2022-03-31v | Standalone | Total assets (5-year summary) |
| Total liabilities | ¥28.4bn | at 2026-03-31 | Standalone | Liabilities |
| Total liabilities | ¥17.6bn | at 2025-03-31 | Standalone | Liabilities |
| Net assets / equity | ¥35.7bn | at 2026-03-31 | Standalone | Net assets |
| Net assets / equity | ¥35.0bn | at 2025-03-31 | Standalone | Net assets |
| Net assets / equity | ¥35.5bn | at 2024-03-31v | Standalone | Net assets |
| Net assets / equity | ¥29.2bn | at 2023-03-31v | Standalone | Net assets (5-year summary) |
| Net assets / equity | ¥27.0bn | at 2022-03-31v | Standalone | Net assets (5-year summary) |
| Cash and deposits | ¥5.8bn | at 2026-03-31 | Standalone | Cash and deposits |
| Cash and deposits | ¥6.0bn | at 2025-03-31 | Standalone | Cash and deposits |
| EPS (basic) | ¥0.54 | 2025-04-01 → 2026-03-31 | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥48.73 | 2024-04-01 → 2025-03-31 | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥49.18 | 2023-04-01 → 2024-03-31v | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥44.71 | 2022-04-01 → 2023-03-31v | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥64.93 | 2021-04-01 → 2022-03-31v | Standalone | Basic earnings loss per share (5-year summary) |
| Dividend per share | ¥20 | 2025-04-01 → 2026-03-31 | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥20 | 2024-04-01 → 2025-03-31 | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥40 | 2023-04-01 → 2024-03-31v | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥40 | 2022-04-01 → 2023-03-31v | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥50 | 2021-04-01 → 2022-03-31v | Standalone | Dividend paid per share (5-year summary) |
| Net assets per share | ¥475.91 | at 2026-03-31 | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥466.62 | at 2025-03-31 | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥473.55 | at 2024-03-31v | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥389.04 | at 2023-03-31v | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥360.21 | at 2022-03-31v | Standalone | Net assets per share (5-year summary) |
| Equity ratio | 55.7% | at 2026-03-31 | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 66.5% | at 2025-03-31 | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 59.1% | at 2024-03-31v | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 57.7% | at 2023-03-31v | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 53.0% | at 2022-03-31v | Standalone | Equity to asset ratio (5-year summary) |
| ROE | 0.1% | 2025-04-01 → 2026-03-31 | Standalone | Rate of return on equity (5-year summary) |
| ROE | 10.4% | 2024-04-01 → 2025-03-31 | Standalone | Rate of return on equity (5-year summary) |
| ROE | 11.4% | 2023-04-01 → 2024-03-31v | Standalone | Rate of return on equity (5-year summary) |
| ROE | 11.9% | 2022-04-01 → 2023-03-31v | Standalone | Rate of return on equity (5-year summary) |
| ROE | 19.7% | 2021-04-01 → 2022-03-31v | Standalone | Rate of return on equity (5-year summary) |
| Shares issued | 75,157,367 | at 2026-03-31 | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 75,140,556 | at 2025-03-31 | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 25,043,888 | at 2024-03-31v | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 25,033,238 | at 2023-03-31v | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 25,021,832 | at 2022-03-31v | Standalone | Total number of issued shares (5-year summary) |
| Employees | 716 | at 2026-03-31 | Standalone | Number of employees |
| Employees | 681 | at 2025-03-31 | Standalone | Number of employees |
| Employees | 623 | at 2024-03-31v | Standalone | Number of employees |
| Employees | 597 | at 2023-03-31v | Standalone | Number of employees |
| Employees | 573 | at 2022-03-31v | Standalone | Number of employees |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 26
| Segment | Item | Period | Value |
|---|---|---|---|
| Medical Devicereportable segment | capex | 2025-04-01 → 2026-03-31 | ¥148m |
| Medical Devicereportable segment | depreciation | 2025-04-01 → 2026-03-31 | ¥147m |
| Medical Devicereportable segment | employees | at 2026-03-31 | 100 pure |
| Medical Devicereportable segment | revenue | 2025-04-01 → 2026-03-31 | ¥2.5bn |
| Medical Devicereportable segment | revenue external | 2025-04-01 → 2026-03-31 | ¥2.5bn |
| Medical Devicereportable segment | segment assets | at 2026-03-31 | ¥3.5bn |
| Medical Devicereportable segment | segment profit | 2025-04-01 → 2026-03-31 | ¥452m |
| Semiconductor Equipmentreportable segment | capex | 2025-04-01 → 2026-03-31 | ¥4.0bn |
| Semiconductor Equipmentreportable segment | depreciation | 2025-04-01 → 2026-03-31 | ¥2.9bn |
| Semiconductor Equipmentreportable segment | employees | at 2026-03-31 | 2006 pure |
| Semiconductor Equipmentreportable segment | revenue | 2025-04-01 → 2026-03-31 | ¥49.9bn |
| Semiconductor Equipmentreportable segment | revenue external | 2025-04-01 → 2026-03-31 | ¥49.9bn |
| Semiconductor Equipmentreportable segment | segment assets | at 2026-03-31 | ¥100.7bn |
| Semiconductor Equipmentreportable segment | segment profit | 2025-04-01 → 2026-03-31 | ¥6.5bn |
| Medical Devicereportable segment | capex | 2024-04-01 → 2025-03-31 | ¥184m |
| Medical Devicereportable segment | depreciation | 2024-04-01 → 2025-03-31 | ¥134m |
| Medical Devicereportable segment | revenue | 2024-04-01 → 2025-03-31 | ¥2.3bn |
| Medical Devicereportable segment | revenue external | 2024-04-01 → 2025-03-31 | ¥2.3bn |
| Medical Devicereportable segment | segment assets | at 2025-03-31 | ¥3.1bn |
| Medical Devicereportable segment | segment profit | 2024-04-01 → 2025-03-31 | ¥453m |
| Semiconductor Equipmentreportable segment | capex | 2024-04-01 → 2025-03-31 | ¥5.1bn |
| Semiconductor Equipmentreportable segment | depreciation | 2024-04-01 → 2025-03-31 | ¥2.4bn |
| Semiconductor Equipmentreportable segment | revenue | 2024-04-01 → 2025-03-31 | ¥49.0bn |
| Semiconductor Equipmentreportable segment | revenue external | 2024-04-01 → 2025-03-31 | ¥49.0bn |
| Semiconductor Equipmentreportable segment | segment assets | at 2025-03-31 | ¥78.3bn |
| Semiconductor Equipmentreportable segment | segment profit | 2024-04-01 → 2025-03-31 | ¥8.4bn |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 1,605
| Item | Context | Value | Unit |
|---|---|---|---|
| Proceeds from long term loans payable fin cf | Prior1YearDuration | － | JPY |
| Proceeds from long term loans payable fin cf | CurrentYearDuration | 5000000000 | JPY |
| Repayment of long term loans payable fin cf | Prior1YearDuration | -1560000000 | JPY |
| Repayment of long term loans payable fin cf | CurrentYearDuration | -1370000000 | JPY |
| Purchase of treasury stock fin cf | Prior1YearDuration | -2111000 | JPY |
| Purchase of treasury stock fin cf | CurrentYearDuration | -1113000 | JPY |
| Cash dividends paid fin cf | Prior1YearDuration | -1001188000 | JPY |
| Cash dividends paid fin cf | CurrentYearDuration | -1501945000 | JPY |
| Other net fin cf | Prior1YearDuration | -162963000 | JPY |
| Other net fin cf | CurrentYearDuration | -197868000 | JPY |
| Net cash provided by used in financing activities | Prior1YearDuration | -5126263000 | JPY |
| Net cash provided by used in financing activities | CurrentYearDuration | 6429072000 | JPY |
| Effect of exchange rate change on cash and cash equivalents | Prior1YearDuration | -615211000 | JPY |
| Effect of exchange rate change on cash and cash equivalents | CurrentYearDuration | 967145000 | JPY |
| Net increase decrease in cash and cash equivalents | Prior1YearDuration | -126886000 | JPY |
| Net increase decrease in cash and cash equivalents | CurrentYearDuration | 5990859000 | JPY |
| Cash and cash equivalents | Prior2YearInstant | 20517272000 | JPY |
| Cash and cash equivalents | Prior1YearInstant | 20390386000 | JPY |
| Cash and cash equivalents | Prior1YearInstant | 20390386000 | JPY |
| Cash and cash equivalents | CurrentYearInstant | 26381245000 | JPY |
| Number of consolidated subsidiaries | CurrentYearInstant | 21 | |
| Write downs of inventories | Prior1YearDuration | 329142000 | JPY |
| Write downs of inventories | CurrentYearDuration | 157665000 | JPY |
| Provision of allowance for doubtful accounts sga | Prior1YearDuration | 4481000 | JPY |
| Provision of allowance for doubtful accounts sga | CurrentYearDuration | 21017000 | JPY |
| Salaries and allowances sga | Prior1YearDuration | 2667735000 | JPY |
| Salaries and allowances sga | CurrentYearDuration | 2884887000 | JPY |
| Provision for bonuses sga | Prior1YearDuration | 362922000 | JPY |
| Provision for bonuses sga | CurrentYearDuration | 375207000 | JPY |
| Provision for directors bonuses sga | Prior1YearDuration | 114586000 | JPY |
| Provision for directors bonuses sga | CurrentYearDuration | 132370000 | JPY |
| Retirement benefit expenses sga | Prior1YearDuration | 63162000 | JPY |
| Retirement benefit expenses sga | CurrentYearDuration | 70999000 | JPY |
| Provision for share based remuneration sga | Prior1YearDuration | 14426000 | JPY |
| Provision for share based remuneration sga | CurrentYearDuration | 19517000 | JPY |
| Commission fee sga | Prior1YearDuration | 1208662000 | JPY |
| Commission fee sga | CurrentYearDuration | 1363132000 | JPY |
| Research and development expenses included in general and administrative expenses | Prior1YearDuration | 1393476000 | JPY |
| Research and development expenses included in general and administrative expenses | CurrentYearDuration | 816964000 | JPY |
| Revenues from external customers | Prior1YearDuration_jpcrp030000-asr_E01708-000SemiconductorEquipmentReportableSegmentsMember | 48959043000 | JPY |
| Revenues from external customers | Prior1YearDuration_jpcrp030000-asr_E01708-000MedicalDeviceReportableSegmentsMember | 2263915000 | JPY |
| Revenues from external customers | Prior1YearDuration_jpcrp030000-asr_E01708-000LaserProcessingMachinesMember | 2256247000 | JPY |
| Revenues from external customers | Prior1YearDuration | 53479205000 | JPY |
| Transactions with other segments | Prior1YearDuration_jpcrp030000-asr_E01708-000SemiconductorEquipmentReportableSegmentsMember | － | JPY |
| Transactions with other segments | Prior1YearDuration_jpcrp030000-asr_E01708-000MedicalDeviceReportableSegmentsMember | － | JPY |
| Transactions with other segments | Prior1YearDuration_jpcrp030000-asr_E01708-000LaserProcessingMachinesMember | － | JPY |
| Transactions with other segments | Prior1YearDuration | － | JPY |
| Net sales | Prior1YearDuration_jpcrp030000-asr_E01708-000SemiconductorEquipmentReportableSegmentsMember | 48959043000 | JPY |
| Net sales | Prior1YearDuration_jpcrp030000-asr_E01708-000MedicalDeviceReportableSegmentsMember | 2263915000 | JPY |
| Net sales | Prior1YearDuration_jpcrp030000-asr_E01708-000LaserProcessingMachinesMember | 2256247000 | JPY |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 24 of 24 passed
| balance sheet identity | pass |
| balance sheet identity | pass rounding |
| balance sheet identity | pass |
| balance sheet identity | pass rounding |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |